Nifedipine

This article examines the use of nifedipine, a calcium channel blocker, in various clinical trials. Nifedipine is primarily studied for its effectiveness in treating hypertension, including during pregnancy, and for preventing preterm labor. The trials investigate different dosing regimens, formulations, and patient populations to optimize nifedipine’s therapeutic benefits while minimizing side effects.

Table of Contents

What is Nifedipine?

Nifedipine is a medication that belongs to a class of drugs called calcium channel blockers. It is known by several brand names, including Adalat, Procardia, and Nifedical[1]. This medication is primarily used to treat high blood pressure (hypertension) and certain heart conditions[2].

Uses of Nifedipine

Nifedipine is used to treat several medical conditions:

  • Hypertension (High Blood Pressure): It is commonly prescribed to lower blood pressure in adults[3].
  • Preterm Labor: In pregnant women, it may be used to stop early labor contractions[4].
  • Preeclampsia: It can be used to manage high blood pressure in pregnant women with severe preeclampsia, a condition characterized by high blood pressure and signs of damage to other organ systems during pregnancy[5].
  • Chronic Hypertension in Pregnancy: It’s used to treat ongoing high blood pressure in pregnant women[2].

How Nifedipine Works

Nifedipine works by relaxing and widening blood vessels. It does this by blocking calcium from entering the cells of the heart and blood vessel walls. This action helps to lower blood pressure and improve blood flow[2]. In pregnant women experiencing preterm labor, nifedipine can help relax the uterine muscles, potentially stopping early contractions[4].

Dosage Forms

Nifedipine comes in several forms:

  • Immediate-release tablets: These provide quick action but need to be taken more frequently[6].
  • Extended-release (XL or CR) tablets: These provide longer-lasting effects and are usually taken once or twice daily. Common doses include 30mg and 60mg tablets[2][1].

The dosage and frequency of nifedipine can vary depending on the condition being treated and the individual patient’s needs. Always follow your doctor’s instructions regarding dosage[5].

Side Effects

Like all medications, nifedipine can cause side effects. Common side effects may include:

  • Headache
  • Flushing (warmth or redness in your face, neck, or chest)
  • Dizziness
  • Fatigue
  • Nausea
  • Constipation
  • Peripheral edema (swelling in the legs or ankles)
  • Muscle cramps[3]

If you experience any severe or persistent side effects, contact your healthcare provider immediately.

Special Considerations

Nifedipine requires special consideration in certain situations:

  • Pregnancy: While nifedipine is often used in pregnancy for managing high blood pressure and preterm labor, it should only be used under close medical supervision[2].
  • Breastfeeding: Small amounts of nifedipine may pass into breast milk. Discuss with your doctor if you’re breastfeeding or plan to breastfeed[7].
  • Other medications: Nifedipine can interact with other drugs. Always inform your doctor about all medications you’re taking[7].

Ongoing Research

Researchers continue to study nifedipine to understand its effects better and optimize its use. Some areas of ongoing research include:

  • Comparing different dosing regimens for managing high blood pressure in pregnancy[5].
  • Investigating its use in improving embryo implantation rates during in vitro fertilization (IVF) treatments[6].
  • Studying how genetic factors might influence an individual’s response to nifedipine[7].

These studies aim to provide more personalized and effective treatment strategies for patients using nifedipine.

Aspect Details
Primary Uses Hypertension treatment, Prevention of preterm labor
Dosage Forms Extended-release tablets (XL, CR, GITS), Immediate-release tablets
Dosage Range 30-60 mg daily for hypertension, 10-120 mg daily for preterm labor
Administration Once daily or twice daily, depending on formulation and condition
Key Trials Hypertension in pregnancy, Preterm labor prevention, IVF embryo implantation
Safety in Pregnancy Generally considered safe, but should be used under medical supervision
Common Side Effects Headache, flushing, dizziness, peripheral edema
Research Focus Optimal dosing regimens, Efficacy comparison, Pharmacokinetics in pregnancy

Ongoing Clinical Trials on Nifedipine

  • Study on Nifedipine for Managing Preterm Premature Rupture of Membranes (PPROM) in Pregnant Women Before 34 Weeks

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

Glossary

  • Antihypertensive: A medication or treatment used to lower high blood pressure.
  • Tocolytic: A medication used to suppress premature labor by reducing uterine contractions.
  • Preeclampsia: A pregnancy complication characterized by high blood pressure and signs of damage to other organ systems, often the liver and kidneys.
  • Gestational hypertension: High blood pressure that develops after 20 weeks of pregnancy in women who previously had normal blood pressure.
  • Extended-release (XL or CR): A formulation of medication designed to release the active ingredient slowly over time, allowing for less frequent dosing.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Pharmacodynamics: The study of the biochemical and physiological effects of drugs on the body and the mechanisms of their actions.
  • In Vitro Fertilization (IVF): A complex series of procedures used to help with fertility or prevent genetic problems and assist with the conception of a child.
  • Uterine contractility: The ability of the uterus to contract, which is important in labor and delivery but can be problematic in preterm labor.
  • Bioavailability: The proportion of a drug or other substance which enters the circulation when introduced into the body and so is able to have an active effect.

References

  1. https://clinicaltrials.gov/study/NCT00865891
  2. https://clinicaltrials.gov/study/NCT03595982
  3. https://clinicaltrials.gov/study/NCT02413515
  4. https://clinicaltrials.gov/study/NCT02090920
  5. https://clinicaltrials.gov/study/NCT05096728
  6. https://clinicaltrials.gov/study/NCT02072291
  7. https://clinicaltrials.gov/study/NCT02068404